{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:54:45Z","timestamp":1787165685469,"version":"build-2736575974"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00957","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:18:29Z","timestamp":1589933909000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris"],"prefix":"10.3389","volume":"11","author":[{"given":"Fruzsina","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Vit\u00e1lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Borman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Forg\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Majoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e1t\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/myc.12886","article-title":"Candida auris otomycosis in Iran and review of recent literature.","volume":"62","author":"Abastabar","year":"2019","journal-title":"Mycoses"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/jam.14248","article-title":"Effect of quorum sensing molecules and natamycin on biofilms of Candida tropicalis and other yeasts isolated from industrial juice filtration membranes.","volume":"126","author":"Agust\u00edn","year":"2019","journal-title":"J. Appl. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1128\/AAC.01584-09","article-title":"In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.","volume":"54","author":"Andes","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3201\/eid2404.171715","article-title":"Candida auris infection leading to nosocomial transmission, Israel, 2017.","volume":"24","author":"Belkin","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1387-2656(05)11004-7","article-title":"Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.","volume":"11","author":"Berridge","year":"2005","journal-title":"Biotechnol. Annu. Rev."},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01393-19","article-title":"In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism.","volume":"63","author":"Bidaud","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00189-16","article-title":"Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species.","volume":"1","author":"Borman","year":"2016","journal-title":"mSphere"},{"key":"B8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/mmy\/myw147","article-title":"Isolates of the emerging pathogen Candia auris present in the UK have several geographic origins.","volume":"55","author":"Borman","year":"2017","journal-title":"Med. Mycol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12275-016-6298-y","article-title":"The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.","volume":"54","author":"Boz\u00f3","year":"2016","journal-title":"J. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/1097-4547(20001101)62:3<396::AID-JNR10>3.0.CO;2-E","article-title":"Farnesol modulates membrane currents in human retinal glial cells.","author":"Bringmann","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01397-19","article-title":"On the emergence of Candida auris: climate change, azoles, swamps, and birds.","volume":"10","author":"Casadevall","year":"2019","journal-title":"mBio"},{"key":"B12","year":"2019","journal-title":"Tracking Candida auris."},{"key":"B13","year":"2020","journal-title":"Antifungal Susceptibility Testing and Interpretation."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3201\/eid2509.190686","article-title":"Potential fifth clade of Candida auris, Iran, 2018.","volume":"25","author":"Chow","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"B15","year":"2008","journal-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard. 3rd ed. M27-A3."},{"key":"B16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2958.2007.06013.x","article-title":"Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis.","volume":"67","author":"Davis-Hanna","year":"2008","journal-title":"Mol. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00506-18","article-title":"Hog1 regulates stress tolerance and virulence in the emerging fungal pathogen Candida auris.","volume":"3","author":"Day","year":"2018","journal-title":"mSphere"},{"key":"B18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/EC.00321-09","article-title":"Farnesol induces hydrogen peroxide resistance in Candida albicans yeast by inhibiting the Ras-cyclic AMP signaling pathway.","volume":"9","author":"Deveau","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"B19","article-title":"First case of Candida auris infection in Belgium in a surgical patient from Kuwait.","author":"Dewaele","year":"2018","journal-title":"Acta Clin. Belg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/jac\/dkz178","article-title":"Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.","volume":"74","author":"Dudiuk","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B21","year":"2018","journal-title":"Candida auris in Healthcare Settings Europe."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJMoa1714373","article-title":"A Candida auris outbreak and its control in an intensive care setting.","volume":"379","author":"Eyre","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01056-17","article-title":"In Vitro interactions of echinocandins with triazoles against multidrug-resistant Candida auris.","volume":"61","author":"Fakhim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/myc.12754","article-title":"Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.","volume":"61","author":"Fakhim","year":"2018","journal-title":"Mycoses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12088-018-0714-4","article-title":"Virulence factors in Candida albicans and Streptococcus mutans biofilms mediated by farnesol.","volume":"58","author":"Fernandes","year":"2018","journal-title":"Indian J. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/mmy\/myx155","article-title":"Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.","volume":"57","author":"Fernandes Costa","year":"2019","journal-title":"Med. Mycol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/09687860500135411","article-title":"Farnesol and geranylgeraniol modulate the structural properties of phosphatidylethanolamine model membranes.","volume":"22","author":"Funari","year":"2005","journal-title":"Mol. Membr. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/02681219680000721","article-title":"Adhesion of different Candida spp. to plastic: XTT formazan determinations.","volume":"34","author":"Hawser","year":"1996","journal-title":"J. Med. Vet. Mycol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1472-765X.2006.02044.x","article-title":"Effect of farnesol on Candida dubliniensis morphogenesis.","volume":"44","author":"Henriques","year":"2007","journal-title":"Lett. Appl. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1348-0421.2008.00044.x","article-title":"Protective effects of farnesol against oral candidiasis in mice.","volume":"52","author":"Hisajima","year":"2008","journal-title":"Microbiol. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1128\/AEM.67.7.2982-2992.2001","article-title":"Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.","volume":"67","author":"Hornby","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1567-1364.2006.00121.x","article-title":"Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.","volume":"6","author":"Jabra-Rizk","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/jobm.201400903","article-title":"Betamethasone augments the antifungal effect of menadione\u2013towards a novel anti-Candida albicans combination therapy.","volume":"55","author":"Jakab","year":"2015","journal-title":"J. Basic Microbiol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01388-19","article-title":"Physiological and transcriptional responses of Candida parapsilosis to exogenous tyrosol.","volume":"85","author":"Jakab","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00029-17","article-title":"Candida auris: a review of the literature.","volume":"31","author":"Jeffery-Smith","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1439-0507.2002.00727.x","article-title":"Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains.","volume":"45","author":"Kantarcioglu","year":"2002","journal-title":"Mycoses"},{"key":"B37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jac\/dku374","article-title":"In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.","volume":"70","author":"Katragkou","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/jof6010030","article-title":"Candida auris: a decade of understanding of an enigmatic pathogenic yeast.","volume":"6","author":"Kean","year":"2020","journal-title":"J. Fungi"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00458-19","article-title":"Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris.","volume":"4","author":"Kean","year":"2019","journal-title":"mSphere"},{"key":"B40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijantimicag.2016.01.007","article-title":"Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.","volume":"47","author":"Kov\u00e1cs","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1099\/jmm.0.066381-0","article-title":"Killing rates exerted by caspofungin in 50% serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.","volume":"63","author":"Kov\u00e1cs","year":"2014","journal-title":"J. Med. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01777-18","article-title":"In Vivo applicability of Neosartorya fischeri antifungal Protein 2 (NFAP2) in treatment of vulvovaginal candidiasis.","volume":"63","author":"Kov\u00e1cs","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s11046-017-0178-9","article-title":"Killing activity of micafungin against Candida albicans, C. dubliniensis and Candida africana in the presence of human serum.","volume":"182","author":"Kov\u00e1cs","year":"2017","journal-title":"Mycopathologia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/JCM.00319-11","article-title":"First three reported cases of nosocomial fungemia caused by Candida auris.","volume":"49","author":"Lee","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses.","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24101950","article-title":"Fungal quorum-sensing molecules and inhibitors with potential antifungal activity: a review.","volume":"24","author":"Mehmood","year":"2019","journal-title":"Molecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/13693780410001731547","article-title":"Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.","volume":"43","author":"Meletiadis","year":"2005","journal-title":"Med. Mycol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/jam.13513","article-title":"Antifungal activity of tyrosol and farnesol used in combination against Candida species in the planktonic state or forming biofilms.","volume":"123","author":"Monteiro","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/mmy\/myz057","article-title":"Farnesol increases the activity of echinocandins against Candida auris biofilms.","volume":"2019","author":"Nagy","year":"2019","journal-title":"Med. Mycol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/jac\/dki383","article-title":"Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.","volume":"56","author":"Navarathna","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1128\/IAI.01182-06","article-title":"Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.","volume":"75","author":"Navarathna","year":"2007","journal-title":"Infect. Immun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris isolates resistant to three classes of antifungal medications - New York, 2019.","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nport.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat. Protoc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/00362178285380031","article-title":"Plate method for detection of phospholipase activity in Candida albicans.","volume":"20","author":"Price","year":"1982","journal-title":"Sabouraudia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1099\/jmm.0.000496","article-title":"Infection and tissue repair of experimental cutaneous candidiasis in diabetic mice.","volume":"66","author":"Pupim","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019703","article-title":"Antifungal drug development: challenges, unmet clinical needs, and new approaches.","volume":"4","author":"Roemer","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1099\/jmm.0.001036","article-title":"Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs.","volume":"68","author":"Romera","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03081","article-title":"Candida auris: what have we learned about its mechanisms of pathogenicity?","volume":"9","author":"Rossato","year":"2018","journal-title":"Front. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1128\/AAC.01438.06","article-title":"Transcriptional response of Candida parapsilosis following exposure to farnesol.","volume":"51","author":"Rossignol","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/IDR.S116229","article-title":"Current perspective on emergence, diagnosis and drug resistance in Candida auris.","volume":"10","author":"Sarma","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of the globally emerging Candida auris in a European hospital.","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"B62","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1593\/neo.08444","article-title":"Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells.","volume":"10","author":"Scheper","year":"2008","journal-title":"Neoplasia"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis.","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front. Microbiol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24030399","article-title":"Metabolic profiling of Candida auris, a newly-emerging multi-drug resistant Candida species, by GC-MS.","volume":"24","author":"Semreen","year":"2019","journal-title":"Molecules"},{"key":"B65","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jinf.2019.09.007","article-title":"Candida auris outbreak: mortality, interventions and cost of sustaining control.","volume":"79","author":"Taori","year":"2019","journal-title":"J. Infect."},{"key":"B66","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/ajt.14121","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016.","volume":"17","author":"Vallabhaneni","year":"2017","journal-title":"Am. J. Transplant."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01084-18","article-title":"Screening a repurposing library for inhibitors of multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for antifungal drug development.","volume":"62","author":"Wall","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/yea.1769","article-title":"The quorum-sensing molecule E, E-farnesol\u2013its variable secretion and its impact on the growth and metabolism of Candida species.","volume":"27","author":"Weber","year":"2010","journal-title":"Yeast"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1128\/AAC.01646-07","article-title":"Secretion of E, E-farnesol and biofilm formation in eight different Candida species.","volume":"52","author":"Weber","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1128\/AAC.05290-11","article-title":"Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.","volume":"56","author":"Yu","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:18:32Z","timestamp":1589933912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":70,"alternative-id":["10.3389\/fmicb.2020.00957"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00957","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"article-number":"957"}}